Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Oxford BioMedica acquires anticancer macrophage technology

May 2, 1997

Emisphere receives notices of allowance for oral delivery technologies

April 28, 1997

LifeCell issued U.S. patent for ThromboSol blood platelet preservation product

April 28, 1997

Biosource awarded grant for human therapeutic protein production

April 25, 1997

Avigen granted patent on high-yield AAV production for gene therapy

April 24, 1997

Hybridon issued patent for pent-enoyl-protected nucleotides

April 23, 1997

Oncor's Sunrise Amplification Detection System presented

April 23, 1997

Genetronics develops electroporation therapy drug delivery system

April 23, 1997

AntiCancer receives grant for development of mouse cancer model

April 21, 1997

Ribozyme and Schering AG to collaborate on target validation and therapeutic development

April 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...